SBIR/STTR Research Award

Disposable Valved Intraurethral Catheter Feasibility

Award identifier bd079034dee2e22758bd194bc769306b7d4a27ea99f034de803156facd6809abAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
UROVALVE, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Urovalve, Inc. has developed a user operated valved catheter to enable people with chronic urinary retention to pursue more active lives and decrease the high incidence of urinary tract infections. The device is a short silicone catheter with a malecot to retain it in the bladder and a miniature proximity valve to control flow. The tiny fluid flow valve is opened by a switching magnet that is held near the body and closes when the magnet is moved away. The device is inserted into the urethra without surgery, is extracted easily, and will be intended to be replaced every 28 days. This research will perform feasibility tests on the intraurethral valved catheter to: refine clinical techniques for insertion and extraction; demonstrate stability of catheter positioning in urethra; demonstrate that the device works effectively and is safe during a short-term trial. Five spinal cord injured subjects having urinary retention but otherwise normal urethras will receive implants and be monitored for four days within a rehabilitation hospital. The stents will bridge the urethral sphincters from bladder neck to bulbous urethra. Subjects will perform normal daily living activities to test stability of stent placement and will be monitored for clinical signs, residual volumes and understanding of valve operation. Subjects will open the valves intermittently using hand held actuator magnets. Implantation methods, using a protective sheath, and removal methods, using an extraction tool, will be tested for safety. Implanted stents will be monitored for: migration from implant position; urine leakage; clogging; and closure due to stent deformation. Stent extraction forces will be measured and recovered stents will be examined for accumulation of renal debris and physical integrity and be cultured for bacteria accumulation. Devices currently available are either very simple catheters (Foley or Intermittent Catheter) or very high tech electro-mechanical devices that require extensive surgical implantation. No inventions currently available or in development combine the utility and health-care cost benefits of Urovalve's invention.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.